<code id='C848F05247'></code><style id='C848F05247'></style>
    • <acronym id='C848F05247'></acronym>
      <center id='C848F05247'><center id='C848F05247'><tfoot id='C848F05247'></tfoot></center><abbr id='C848F05247'><dir id='C848F05247'><tfoot id='C848F05247'></tfoot><noframes id='C848F05247'>

    • <optgroup id='C848F05247'><strike id='C848F05247'><sup id='C848F05247'></sup></strike><code id='C848F05247'></code></optgroup>
        1. <b id='C848F05247'><label id='C848F05247'><select id='C848F05247'><dt id='C848F05247'><span id='C848F05247'></span></dt></select></label></b><u id='C848F05247'></u>
          <i id='C848F05247'><strike id='C848F05247'><tt id='C848F05247'><pre id='C848F05247'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:61
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Biogen’s boardroom scandal saddles CEO with first crisis
          Biogen’s boardroom scandal saddles CEO with first crisis

          ChrisViehbachertookoverasBiogenCEOinNovember.SuzanneKreiter/Globestaff;PhotoillustrationAlexHogan/ST

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

          3:04PeoplegatheraroundandcheerforKaiCenat,center,asmembersoftheNYPDrespondtothousandsofpeoplegathere